LISA MERRITT: Open Payments
NPI 1407496649 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,730 in 115 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,126 · 2025 $3,730
Food & beverage: $3,730
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $1,210 |
| GlaxoSmithKline, LLC. | 31 | $797 |
| Regeneron Healthcare Solutions, Inc. | 13 | $550 |
| Grifols USA, LLC | 10 | $303 |
| Lilly USA, LLC | 6 | $215 |
| Verona Pharma, Inc. | 7 | $175 |
| Electromed, Inc. | 7 | $175 |
| Astellas Pharma US Inc | 2 | $66 |
| Amgen Inc. | 3 | $60 |
| Actelion Pharmaceuticals US, Inc. | 2 | $57 |
Products named: NUCALA, DUPIXENT, TEZSPIRE, AIRSUPRA, Prolastin-C Liquid, BREZTRI, ZEPBOUND, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
